secwatch.observer — SEC 8-K summary
======================================

Issuer:     Instil Bio, Inc. (TIL)
CIK:        0001789769
Form:       8-K
Filed at:   2024-08-15T23:59:59+00:00
Accession:  0001789769-24-000090
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Instil Bio provides SYN-2510 program overview in investor presentation
----------------------------------------------------------------------

- Company furnished presentation detailing its SYN-2510 program as of August 2024.
- No specific clinical data, milestones, or financial projections disclosed in the filing.
- The program overview does not include any changes to previously disclosed guidance or plans.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1789769/000178976924000090/0001789769-24-000090-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1789769/000178976924000090/til-20240815.htm
  HTML page:      https://secwatch.observer/filing/0001789769-24-000090

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer